YACHMETZ PHILIP K 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Mar 7, 2013
Insider Transaction Report
Form 4
YACHMETZ PHILIP K
SVP, General Counsel
Transactions
- Award
Option to Purchase Common Stock
2013-03-05+110,000→ 110,000 totalExercise: $0.94Exp: 2023-03-05→ Common Stock (110,000 underlying) - Award
Option to Purchase Common Stock
2013-03-05+78,000→ 78,000 totalExercise: $2.26Exp: 2022-02-01→ Common Stock (78,000 underlying)
Footnotes (2)
- [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
- [F2]These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.